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Background: We studied the incidence, trend, underlying conditions, microbiology, and outcomes
of infective endocarditis (IE) in children during 11 years using Nationwide Inpatient Sample (NIS)
database. This is the largest all-payer inpatient care database in the United States containing data
for more than 8 million hospital stays from over 1000 hospitals.
Methods: NIS data from 2000 to 2010 of primary discharge diagnosis of IE in children aged 19
years old were studied. Children with underlying congenital heart defects and acquired heart con-
ditions were identified. Microbiological causative agents were recorded. Linear regression was
used to assess trend of incidence over time.
Results: An estimated 3,840 (95% CI: 3,395-4,285) children had a discharge diagnosis of IE. The
overall incidence was 0.43 per 100 000 children. The incidence was stable over the study period
(P5 .4 for trend). The majority of patients 56.2% were 11 years old and 15.4% were1 year.
Underlying cardiac conditions were present in 53.5% of patients. Overall 30.2% of cases were
culture-negative. Among those with identified pathogens, Staphylococcus species were most com-
mon (43.1%) followed by Streptococcus species (39.5%). Viridans Streptococcus group was most
common in those with underlying heart disease (32.7%) and S. aureus was most common in those
without heart disease (46.9%). Among culture-positive patients, there was a decline in proportion
of Staphylococcal IE (P5 .03) and an increase in proportion of Streptococcal IE (P5 .04). Overall
mortality was 2.8%. Patients with Staphylococcal IE had longer median length of stay (12 vs. 9
days; P< .01) and the highest mortality (4.7%).
Conclusion: The incidence of IE in children has remained unchanged in the United States during
the 11-year study period. Among culture-positive patients there was a significant decrease in
Staphylococcal IE and a significant increase of Streptococcal IE. Staphylococcal IE was associated
with increased LOS and highest mortality.
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1 | INTRODUCTION
During the past decade there has been an increase in the risk factors
for infective endocarditis (IE). The advancements in cardiovascular sur-
gery have led to improved survival of children with congenital heart
disease (CHD) beyond infancy and into adulthood.1 These children are
at increased risk of developing postoperative infections including IE
due to presence of prosthetic devices placed for correction or palliation
of heart defects.2–5 There has also been an increase in the use of
central venous catheters in children for medication infusion and blood
drawing, thus increasing the risk of catheter-related infections, includ-
ing IE.6 With the increase in these risk factors, there is an expected
increase in incidence of endocarditis. Also, the advancements in micro-
biologic techniques has lead to improved recovery and better identifi-
cation of organisms in blood and tissue cultures, thereby improving the
etiologic diagnosis of previously culture-negative labeled IE cases.
The overall incidence of endocarditis has increased during the past
several years. In a recent report by Bor et al., during the period 1998-
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2009 hospital admissions for IE in the United States rose from 25 511
(9.3 per 100 000 population) to 38 976 (12.7 per 100 000 population).
The endocarditis admission rate increased 2.4% annually after adjust-
ment for population growth and aging. Pediatric cases (<18 years)
accounted for 1.9% of total cases.7 In a more recent report by Pant
et al., based on national data for the period 2000–2011 the incidence
of IE increased from 11 per 100 000 in US population to 15 per
100 000.8
In children, hospitalization rates due to infective endocarditis (IE) are
lower as compared to adults. One report from a single institution esti-
mated that IE cases during 1972 to 1982 accounted for 1 in every 1280
(0.78 per 1000) pediatric admissions annually.9 More recent data from a
multicenter study estimated that there were between 0.05 to 0.12 IE
cases per 1000 hospital admissions during 2003 to 2010.10,11 IE inci-
dence is higher in children with underlying congenital heart disease
(CHD) and was estimated as a cumulative incidence of 6.1 per 1000 chil-
dren.12 There is paucity of data regarding recent national trends of IE in
children. We used a nationally representative sample of hospitalized chil-
dren to assess the recent trends in incidence, microbiology and outcome
of infective endocarditis during the period 2000–2010.
2 | METHODS
2.1 | Study design and data source
We performed a retrospective study using national data from the
Healthcare Cost and Utilization Project—Nationwide Inpatient Sam-
ple (NIS). NIS is the largest all-payer inpatient care database publicly
available in the United States that contains data from a 20% strati-
fied sample of U.S. community hospital.13 Each hospitalization is
treated as an individual database entry and information regarding
common demographic variables—age, race and sex along with pri-
mary insurance, hospital characteristics—teaching status, location
(rural vs. urban), size of hospital and hospital region are available.
Data from 2000 to 2010 period were used for this study. We used
the provided principal diagnosis, secondary diagnoses and proce-
dural diagnoses associated with each hospitalization in the database
for this study.
2.2 | Study population
We included hospitalizations of patients with age19 years. In accord-
ance with previous literature7 we defined infective endocarditis as des-
ignated by the International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) codes for acute and subacute endo-
carditis (421.X), gonococcal endocarditis (098.84), meningococcal endo-
carditis (036.42), candidal endocarditis (112.81) and histoplasma
endocarditis (115.04, 115.14, 115.94).7 We excluded those with
noninfectious or chronic endocarditis.
2.3 | Study variables
We identified demographic characteristics (age, sex, and race), hos-
pital characteristics (teaching status, location, bed size and region)
and primary payer using appropriate variables from the NIS data-
base. The causative organisms and predisposing cardiac conditions
using ICD-9-CM codes are detailed in Supporting Information Tables
S1 and S2.
2.3.1 | Outcomes
Our primary outcome of interest was all cause in-hospital mortality.
We also looked at length of stay (LOS) for those hospitalized with IE. In
addition, we looked at complications of IE during that hospitalization—
acute kidney injury (AKI), stroke, mechanical ventilation use, acute
myocardial infarction, central nervous system (CNS) abscess, meningi-
tis, encephalopathy, convulsions and extracorporeal membrane oxy-
genation (ECMO) use. We assessed the proportion of those
undergoing cardiac valve replacement during that admission. The ICD-
9-CM codes used to identify these complications are provided in Sup-
porting Information Table S3.
2.4 | Statistical analysis
We performed all statistical analysis using STATA 13.1 (College Station,
Texas, USA). Using the weights provided in NIS database, we gener-
ated national estimates for the number of overall IE hospitalizations.
The incidence of IE hospitalizations per 100 000 population was calcu-
lated by utilizing annual population estimates from the United States
Census Bureau. We used the chi-square test to compare categorical
variables and linear regression to assess the significance of trends over
time. A P value of .05 was deemed significant.
3 | RESULTS
3.1 | Incidence of IE
An estimated 3,840 (95% CI: 3,395–4,285) children had a discharge
diagnosis of IE. Children accounted for 2% of the total hospitalizations
for IE during the study period. The overall incidence of IE was 0.43 per
100 000 children and was stable over the study period (P5 .4 for
trend) (Figure 1).
FIGURE 1 Incidence trends of infective endocarditis in US
children during 2000-2010
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3.2 | Study population demographics and
hospital status
The general characteristics of the study population and treating hos-
pital are summarized in Table 1. The majority of patients, 56.2%,
were 11–19 years old and 15.4% were1 year old. Males com-
prised 54.0% of patients, 45.9% were white, 13.7% black, and 13.7%
Hispanic.
Underlying cardiac conditions were present in 53.5% of patients.
These subjects were mostly 10 years old, male, and white. They were
also more often admitted to teaching hospitals (84.9%) when compared
to patients without underlying cardiac conditions (78.5%) (P5 .06).
Among those with cardiac conditions, 81.4% had congenital heart dis-
ease, 15.2% rheumatic heart disease, 7.5% prosthetic valve, 3.9% car-
diac device, and 3.6% had cardiomyopathy. The most common
congenital heart defect was ventricular septal defect (32.2%). Cyanotic
heart defect accounted for 25% of congenital heart defects.
3.3 | Microbiology
A code for any organism was not included in 30.2% of IE discharges
and thus were considered culture-negative. In those with culture-
positive IE, Staphylococcus species were the most common (43.1%
hospitalizations) pathogen followed by Streptococcus species (39.5%).
When categorized further, Staphylococcus aureus accounted for 36.6%
of hospitalizations and viridans Streptococcus Group (VSG) for 26%
whereas 11.1% of hospitalizations were coded for more than one
microorganism (Figure 2). VSG was the most common pathogen in
those with underlying heart condition (32.7%) and S. aureus was most
common in those without underlying heart condition (46.9%) (Table 2).
Among patients with positive cultures, the proportion of Staphylo-
coccal IE decreased from 46.9% in 2000 to 33.1% in 2010 (P5 .03 for
trend) whereas the proportion of Strep spp. IE increased from 35.1% in
2000 to 45.0% in 2010 (P5 .04 for trend).
3.4 | Outcomes
The overall mortality of IE during the study period was 2.8%. Mortality
was higher in those with staphylococcal IE in comparison to non-
staphylococcal IE (4.7% vs. 1.9%; P5 .04) (Table 3). The median length
TABLE 1 Demographics of US children with infective endocarditis



























a19.1% of cases did not have data on race/ethnicity.
FIGURE 2 Distribution (%) of microorganisms isolated in culture-
positive infective endocarditis cases in US children during 2000–
2010
TABLE 2 Causative organisms of infective endocarditis in US chil-








S. aureus 28.1% 46.9%
Other Staph spp 6.6% 6.3%
Viridans Strep. 32.7% 17.9%
Other Strep 16.5% 9.9%
Gram-negative bacilli 5.3% 7.5%
Polymicrobial 10.9% 11.5%
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of hospital stay was 10 days (IQR 5-19d). Median length of stay was
longer by 3 days in patients with Staphylococcus species infection
compared to those with other causative organisms (12d vs. 9d;
P< .001). Median hospital length of stay was not different between
those with or without underlying cardiac conditions.
Overall 7.1% of IE patients had evidence of acute kidney injury
(AKI). Proportion of AKI was higher in those with staphylococcal IE
vs. non-staphylococcal IE (10.8% vs. 5.5%; P5 .006). AKI occurred
less often in children with underlying cardiac condition than those
without (5.0% vs. 9.5%; P5 .02). Mechanical ventilation was used in
7.8% of all patients. There was a trend for increased use of mechani-
cal ventilation in those with staphylococcal IE compared to others
(10.3% vs. 6.8%; P5 .07). Stroke was seen in 5.6% of patients. The
proportion was similar between those with and without cardiac con-
ditions as well as those with staphylococcal IE vs. others. Cardiac
valve replacement surgery was performed in 9.2% of patients. Com-
plications of acute myocardial infarction, CNS abscess, meningitis,
encephalopathy, convulsions and ECMO use were too few for
meaningful interpretation.
4 | DISCUSSION
Using nationally representative data our study showed that the mean
incidence of infective endocarditis in children was 0.43 per 100 000
children with a stable annual incidence during the 11-year study period.
Staphylococcus species were the most commonly recovered pathogens
from patients with culture-positive IE. Staphylococcal IE was also asso-
ciated with longer LOS and had the highest mortality rate. However,
the proportion of staphylococcal IE showed a decline during the study
period.
Infective endocarditis incidence of 0.43 per 100 000 children
noted in our study is similar to previously reported regional and
national estimates that varied between 0.34 to 0.64 per 100 000 chil-
dren.14,15 The incidence of IE in the pediatric population is lower than
that in adults, which was most recently reported to be 15 per 100 000
population.8
During the study period there was a stable trend in the inci-
dence of IE in children, which is similar to what Pasquali et al.
reported recently.10 This is, however, in contrast to the increasing
trends of IE in the adult population recently reported by Pant et al.8
This increasing incidence has been attributed to an increase in the
size of at risk population, such as older, diabetic, and hemodialysis-
dependent patients.16,17
Day et al. had previously described a bi-modal age distribution of
IE cases with peaks in infancy and later teens during the period 2000–
2003.18 In our study, however, the majority of IE cases were in children
11 years and older (56.2%). There was also a high proportion of IE
cases in children without underlying cardiac conditions (46%) which is
similar to previously reported estimates from multicenter hospitaliza-
tion data in which 58% of IE cases did not have underlying cardiac con-
dition identified.18 This could possibly represent undiagnosed or
missed cardiac conditions in children with IE during late childhood. In
contrast, Rosenthal et al. reported a decreasing proportion of IE in chil-
dren with no underlying heart disease from 31% to 18% during 1977
to 2004.19 However, their data were from a single children’s hospital
that served as a referral center for children with congenital heart dis-
ease leading to sampling bias.
In our study 30.2% of the hospitalizations were not coded for
an organism, which is within the range of previously reported inci-
dence range of 2.5 to 31% of culture-negative IE.20 Most common
causes for culture-negative IE are either antimicrobial therapy prior
to obtaining blood cultures or IE caused by pathogens that are slow
growing or difficult to recover by standard blood culture techniques.
We saw a trend towards decline in the incidence of culture-negative
IE cases from 35.5% in 2000 to 18.3% in 2010 (P5 .06 for trend).
We speculate that this is likely due to improvement in molecular
diagnostic techniques to identify 16s Ribosomal RNA or DNA from
tissue or blood.21
In a recent study by Day et al. Staphylococci or Streptococci were
the predominant IE pathogens identified in more than 90% of their
culture-positive cases.18 The majority of our study culture-positive IE
cases were caused by Staphylococcus species (43.1% hospitalizations)
followed by Streptococcus species (39.5%). However, there was a
decline in staphylococcal IE over the study period. This is in contrast to
recent trend noted in adult IE cases as reported by Pant et al. where
they were relative increase in staphylococcal IE of 18.9% during the
period of 2000 to 2011.8 We found an increasing trend for streptococ-
cal IE during the study period (P for trend5 .04). We wanted to assess
the impact of the 2007 ACC/AHA IE antibiotic prophylaxis guidelines
on rates of streptococcal IE.22 The 2007 guidelines limited the antibi-
otic prophylaxis to specific at risk population as well as prophylaxis
prior to gastrointestinal or genitourinary procedures was no longer rec-
ommended. We found that the incidence of IE in children during the
periods before and after the release of the 2007 guidelines remained
unchanged thus providing support in favor of the new guidelines. This
is concordant with previously reported studies where no change was
noted during similar period (7, 10, 23, 24). However, Pant et al.8, using
the NIS database found that the incidence of streptococcal IE has
TABLE 3 Difference in outcomes of US children with Staphylococ-








LOS 12 days 9 days <.001
Complications
Acute kidney injury 10.8% 5.5% .006




Mortality 4.7% 1.9% .04
aIncludes culture-negative IE cases.
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increased since the release of the new guidelines. Differences in char-
acteristics of patients (adults vs. children) and less need for invasive
procedures that could result in bacteremia may account for the differ-
ences in results. Further studies are needed to better understand the
impact of the guidelines in different populations. This result is concord-
ant with previously reported studies where no change was noted dur-
ing similar period.7,10,23,24
The overall mortality for IE cases in our present study was 2.8%,
as compared to previously reported mortality rates of 1.1%-18%.10,25
Staphylococcal IE was associated with increased mortality that is anec-
dotally reported in multiple reports, especially with S. aureus.4,18,25,26
Staphylococcal IE was also associated with significant morbidity with
increased use of mechanical ventilation and acute kidney injury.
Although we have used a nationally representative database, our
study has important limitations. First, we used ICD-9-CM codes for
identification of patients with infective endocarditis. Although, this
methodology has been used in both adult and pediatric studies, we
cannot exclude variations in coding practices that may have led to over
or underestimation of IE incidence rates. Also we were unable to ascer-
tain if these cases fulfilled the Modified Duke criteria for diagnosis of
IE as well as further classification of IE. Limited microbiologic data
were available with the ICD-9-CM coding and data describing which
heart valves were affected could not be ascertained. Possible coding
errors as well as lack of information after discharge including total
treatment duration pose considerable limitation to the study. Second,
as NIS does not have unique patient identifiers, we were unable to
identify readmissions or transfers between hospitals. Lastly, the out-
come data could not be further subcategorized according to different
IE pathogens because of very few numbers of such patients.
5 | CONCLUSIONS
Our study has several important findings. First, the incidence of IE in
children has remained stable during the study period. Second, S. aureus
was the commonest causative organism in pediatric IE cases; however,
there was a declining trend during the study period. Staphylococcal IE
was associated with higher mortality, LOS, AKI, and need for mechani-
cal ventilation. Third, the trend for streptococcal IE related hospitaliza-
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